| Year |
Citation |
Score |
| 2016 |
Zhong C, Wen W, Xia S. [Cost and effectiveness analysis of treatments for benign prostatic hyperplasia]. Zhonghua Yi Xue Za Zhi. 96: 289-92. PMID 26879791 |
0.367 |
|
| 2011 |
Zhong C, Ding J. New G-protein-coupled receptor structures provide insights into the recognition of CXCL12 and HIV-1 gp120 by CXCR4. Acta Biochimica Et Biophysica Sinica. 43: 337-8. PMID 21459858 DOI: 10.1093/Abbs/Gmr026 |
0.307 |
|
| 2010 |
Lim M, Zhong C, Yang S, Bell AM, Cohen MB, Roy-Burman P. Runx2 regulates survivin expression in prostate cancer cells. Laboratory Investigation; a Journal of Technical Methods and Pathology. 90: 222-33. PMID 19949374 DOI: 10.1038/Labinvest.2009.128 |
0.755 |
|
| 2009 |
Dong X, Yang B, Li Y, Zhong C, Ding J. Molecular basis of the acceleration of the GDP-GTP exchange of human ras homolog enriched in brain by human translationally controlled tumor protein. The Journal of Biological Chemistry. 284: 23754-64. PMID 19570981 DOI: 10.1074/Jbc.M109.012823 |
0.312 |
|
| 2007 |
Liao CP, Zhong C, Saribekyan G, Bading J, Park R, Conti PS, Moats R, Berns A, Shi W, Zhou Z, Nikitin AY, Roy-Burman P. Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence. Cancer Research. 67: 7525-33. PMID 17671224 DOI: 10.1158/0008-5472.Can-07-0668 |
0.737 |
|
| 2006 |
Zhong C, Saribekyan G, Liao CP, Cohen MB, Roy-Burman P. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis. Cancer Research. 66: 2188-94. PMID 16489020 DOI: 10.1158/0008-5472.Can-05-3440 |
0.74 |
|
| 2006 |
Khodavirdi AC, Song Z, Yang S, Zhong C, Wang S, Wu H, Pritchard C, Nelson PS, Roy-Burman P. Increased expression of osteopontin contributes to the progression of prostate cancer. Cancer Research. 66: 883-8. PMID 16424021 DOI: 10.1158/0008-5472.Can-05-2816 |
0.71 |
|
| 2005 |
Yang S, Zhong C, Frenkel B, Reddi AH, Roy-Burman P. Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Cancer Research. 65: 5769-77. PMID 15994952 DOI: 10.1158/0008-5472.Can-05-0289 |
0.746 |
|
| 2005 |
Xia G, Kumar SR, Masood R, Zhu S, Reddy R, Krasnoperov V, Quinn DI, Henshall SM, Sutherland RL, Pinski JK, Daneshmand S, Buscarini M, Stein JP, Zhong C, Broek D, et al. EphB4 expression and biological significance in prostate cancer. Cancer Research. 65: 4623-32. PMID 15930280 DOI: 10.1158/0008-5472.Can-04-2667 |
0.724 |
|
| 2003 |
Zhong C, Yang S, Huang J, Cohen MB, Roy-Burman P. Aberration in the expression of the retinoid receptor, RXRalpha, in prostate cancer. Cancer Biology & Therapy. 2: 179-84. PMID 12750559 DOI: 10.4161/Cbt.2.2.281 |
0.764 |
|
| 2003 |
Pan J, Zhong C, Chang Z, Roy-Burman P. A potential therapeutic strategy to combat leukemia virus infection. Cancer Biology & Therapy. 2: 92-9. PMID 12673127 DOI: 10.4161/Cbt.236 |
0.636 |
|
| Show low-probability matches. |